Standard
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. / Pedersen, Susanne Juhl; Sørensen, Inge Juul; Garnero, Patrick; Johansen, Julia Sidenius; Madsen, Ole Rintek; Tvede, Niels; Hansen, Michael Sejer; Thamsborg, Gorm; Andersen, Lis Smedegaard; Majgaard, Ole; Loft, Anne Gitte; Erlendsson, Jon; Asmussen, Karsten; Jurik, Anne Grethe; Møller, Jakob; Hasselquist, Maria; Mikkelsen, Dorrit; Skjødt, Thomas; Lambert, Robert; Hansen, Annette; Østergaard, Mikkel.
I:
Annals of the Rheumatic Diseases, Bind 70, Nr. 8, 2011, s. 1375-81.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Pedersen, SJ, Sørensen, IJ, Garnero, P
, Johansen, JS, Madsen, OR, Tvede, N, Hansen, MS, Thamsborg, G, Andersen, LS, Majgaard, O, Loft, AG, Erlendsson, J, Asmussen, K, Jurik, AG, Møller, J, Hasselquist, M, Mikkelsen, D, Skjødt, T, Lambert, R, Hansen, A
& Østergaard, M 2011, '
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors',
Annals of the Rheumatic Diseases, bind 70, nr. 8, s. 1375-81.
https://doi.org/10.1136/ard.2010.138883APA
Pedersen, S. J., Sørensen, I. J., Garnero, P.
, Johansen, J. S., Madsen, O. R., Tvede, N., Hansen, M. S., Thamsborg, G., Andersen, L. S., Majgaard, O., Loft, A. G., Erlendsson, J., Asmussen, K., Jurik, A. G., Møller, J., Hasselquist, M., Mikkelsen, D., Skjødt, T., Lambert, R.
, ... Østergaard, M. (2011).
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Annals of the Rheumatic Diseases,
70(8), 1375-81.
https://doi.org/10.1136/ard.2010.138883Vancouver
Pedersen SJ, Sørensen IJ, Garnero P
, Johansen JS, Madsen OR, Tvede N o.a.
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Annals of the Rheumatic Diseases. 2011;70(8):1375-81.
https://doi.org/10.1136/ard.2010.138883Author
Pedersen, Susanne Juhl ; Sørensen, Inge Juul ; Garnero, Patrick ; Johansen, Julia Sidenius ; Madsen, Ole Rintek ; Tvede, Niels ; Hansen, Michael Sejer ; Thamsborg, Gorm ; Andersen, Lis Smedegaard ; Majgaard, Ole ; Loft, Anne Gitte ; Erlendsson, Jon ; Asmussen, Karsten ; Jurik, Anne Grethe ; Møller, Jakob ; Hasselquist, Maria ; Mikkelsen, Dorrit ; Skjødt, Thomas ; Lambert, Robert ; Hansen, Annette ; Østergaard, Mikkel. / ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. I: Annals of the Rheumatic Diseases. 2011 ; Bind 70, Nr. 8. s. 1375-81.
Bibtex
@article{fc14d7ec1cb7434db91ffe0146bc815d,
title = "ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors",
abstract = "To investigate the relation between ankylosing spondylitis disease activity score (ASDAS), Bath ankylosing spondylitis disease activity index (BASDAI) and treatment response and biomarkers of inflammation (C-reactive protein (CRP), interleukin-6 (IL-6), YKL-40), angiogenesis (vascular endothelial growth factor (VEGF)), cartilage (C-terminal crosslinking telopeptide of type II collagen (CTX-II), matrix metalloproteinase-3 (MMP-3), total aggrecan, cartilage oligomeric matrix protein) and bone (C-terminal crosslinking telopeptide of type I collagen, osteocalcin) turnover in 60 patients with axial spondyloarthritis initiating tumour necrosis factor alpha (TNFa) inhibitor therapy.",
author = "Pedersen, {Susanne Juhl} and S{\o}rensen, {Inge Juul} and Patrick Garnero and Johansen, {Julia Sidenius} and Madsen, {Ole Rintek} and Niels Tvede and Hansen, {Michael Sejer} and Gorm Thamsborg and Andersen, {Lis Smedegaard} and Ole Majgaard and Loft, {Anne Gitte} and Jon Erlendsson and Karsten Asmussen and Jurik, {Anne Grethe} and Jakob M{\o}ller and Maria Hasselquist and Dorrit Mikkelsen and Thomas Skj{\o}dt and Robert Lambert and Annette Hansen and Mikkel {\O}stergaard",
year = "2011",
doi = "http://dx.doi.org/10.1136/ard.2010.138883",
language = "English",
volume = "70",
pages = "1375--81",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "8",
}
RIS
TY - JOUR
T1 - ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors
AU - Pedersen, Susanne Juhl
AU - Sørensen, Inge Juul
AU - Garnero, Patrick
AU - Johansen, Julia Sidenius
AU - Madsen, Ole Rintek
AU - Tvede, Niels
AU - Hansen, Michael Sejer
AU - Thamsborg, Gorm
AU - Andersen, Lis Smedegaard
AU - Majgaard, Ole
AU - Loft, Anne Gitte
AU - Erlendsson, Jon
AU - Asmussen, Karsten
AU - Jurik, Anne Grethe
AU - Møller, Jakob
AU - Hasselquist, Maria
AU - Mikkelsen, Dorrit
AU - Skjødt, Thomas
AU - Lambert, Robert
AU - Hansen, Annette
AU - Østergaard, Mikkel
PY - 2011
Y1 - 2011
N2 - To investigate the relation between ankylosing spondylitis disease activity score (ASDAS), Bath ankylosing spondylitis disease activity index (BASDAI) and treatment response and biomarkers of inflammation (C-reactive protein (CRP), interleukin-6 (IL-6), YKL-40), angiogenesis (vascular endothelial growth factor (VEGF)), cartilage (C-terminal crosslinking telopeptide of type II collagen (CTX-II), matrix metalloproteinase-3 (MMP-3), total aggrecan, cartilage oligomeric matrix protein) and bone (C-terminal crosslinking telopeptide of type I collagen, osteocalcin) turnover in 60 patients with axial spondyloarthritis initiating tumour necrosis factor alpha (TNFa) inhibitor therapy.
AB - To investigate the relation between ankylosing spondylitis disease activity score (ASDAS), Bath ankylosing spondylitis disease activity index (BASDAI) and treatment response and biomarkers of inflammation (C-reactive protein (CRP), interleukin-6 (IL-6), YKL-40), angiogenesis (vascular endothelial growth factor (VEGF)), cartilage (C-terminal crosslinking telopeptide of type II collagen (CTX-II), matrix metalloproteinase-3 (MMP-3), total aggrecan, cartilage oligomeric matrix protein) and bone (C-terminal crosslinking telopeptide of type I collagen, osteocalcin) turnover in 60 patients with axial spondyloarthritis initiating tumour necrosis factor alpha (TNFa) inhibitor therapy.
U2 - http://dx.doi.org/10.1136/ard.2010.138883
DO - http://dx.doi.org/10.1136/ard.2010.138883
M3 - Journal article
VL - 70
SP - 1375
EP - 1381
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
IS - 8
ER -
